RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Current Quarter	$-0.09	Next Quarter	$0.24
Current Year	$0.67	Next Year	$1.08
QoQ Growth	+366.7%	YoY Growth	+61.2%
3Y EPS CAGR	-56.0%	Target Price	$91.63
Consensus	Buy	Upside	+63.4%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	RDNT	$56.07	+0.29%	620.45K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	RDNT	$56.07	+0.3%	620.45K
3
4
5
6

RDNT

RDNT

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get RadNet Inc. Data in Excel

Get RadNet Inc. Data in Excel